PMID- 35025836
OWN - NLM
STAT- MEDLINE
DCOM- 20220405
LR  - 20230821
IS  - 2327-6924 (Electronic)
IS  - 2327-6886 (Linking)
VI  - 34
IP  - 4
DP  - 2022 Jan 12
TI  - Type 2 diabetes mellitus screening rates in racial and ethnic minority groups.
PG  - 683-687
LID - 10.1097/JXX.0000000000000687 [doi]
AB  - BACKGROUND: More than 7 million Americans aged 18 years and older have 
      undiagnosed diabetes. As primary health care moves toward preventative medicine, 
      it is important that diabetes screening deficits are addressed. PURPOSE: The 
      purpose of this study was to identify current screening rates among racial and 
      ethnic minorities who are considered at high risk of developing type 2 diabetes 
      mellitus (T2DM). METHODOLOGY: Data were collected through an IRB-approved i2b2 
      database from previously consented patients who had been treated at a large 
      academic health center and outpatient facilities. Patients who were included in 
      this study were those seen in outpatient settings between June 2011 and June 
      2019, aged 18-39 years at high risk for developing T2DM, defined as those of a 
      racial and ethnic minority background, obese, and with a family history of T2DM. 
      RESULTS: Approximately 1,476 +/- 3 individuals were identified as high risk, and of 
      those, only 106 +/- 3 (13.9%) were screened for T2DM between June 2011 and June 
      2019. Following the American Diabetes Association guidelines of including body 
      mass index >/=25 kg/m2, approximately 1,263 +/- 3 of the original 1,476 patients were 
      identified as overweight with high risk, and of those patients, only 90 +/- 3 
      (13.8%) were screened. CONCLUSIONS: Findings indicate that less than 14% of 
      patients at high risk for developing T2DM in their lifetime are being screened. 
      IMPLEMENTATIONS: Screening strategies need to be developed and implemented to 
      better identify individuals at high risk of developing T2DM, which may lead to 
      earlier diagnosis, treatment, and decreased disease burden.
CI  - Copyright (c) 2022 American Association of Nurse Practitioners.
FAU - Joy, Alexa J
AU  - Joy AJ
AD  - University of Florida, College of Nursing, Gainesville, Florida.
FAU - Duckworth, Laurie
AU  - Duckworth L
FAU - Scarton, Lisa
AU  - Scarton L
LA  - eng
PT  - Journal Article
DEP - 20220112
PL  - United States
TA  - J Am Assoc Nurse Pract
JT  - Journal of the American Association of Nurse Practitioners
JID - 101600770
MH  - Adolescent
MH  - Adult
MH  - *Diabetes Mellitus, Type 2/therapy
MH  - Ethnic and Racial Minorities
MH  - *Ethnicity
MH  - Humans
MH  - Minority Groups
MH  - Racial Groups
MH  - Young Adult
COIS- Competing interests: The authors report no conflicts of interest.
EDAT- 2022/01/14 06:00
MHDA- 2022/04/06 06:00
CRDT- 2022/01/13 17:25
PHST- 2021/09/02 00:00 [received]
PHST- 2021/11/19 00:00 [accepted]
PHST- 2022/01/14 06:00 [pubmed]
PHST- 2022/04/06 06:00 [medline]
PHST- 2022/01/13 17:25 [entrez]
AID - 01741002-202204000-00012 [pii]
AID - 10.1097/JXX.0000000000000687 [doi]
PST - epublish
SO  - J Am Assoc Nurse Pract. 2022 Jan 12;34(4):683-687. doi: 
      10.1097/JXX.0000000000000687.